Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

ISA 2020

AL Amyloidosis

View all
6:10
Auto-HSCT in AL amyloidosis
Eli Muchtar • 9 Sep 2020
2:20
New prognostic markers in AL amyloidosis
Efstathios Kastritis • 15 Sep 2020
2:00
AL amyloidosis: Hot topics from ISA 2020
Vaishali Sanchorawala • 15 Sep 2020
5:43
Optimism for amyloidosis therapy
Joel Buxbaum • 3 Sep 2020

Therapy Updates

View all
6:29
Amyloid disease: aiming for a cure
Giampaolo Merlini • 1 Sep 2020
3:19
Supportive care in AL amyloidosis
Joan Bladé • 2 Sep 2020
6:10
Auto-HSCT in AL amyloidosis
Eli Muchtar • 9 Sep 2020
2:45
Burning questions: ASCT in AL amyloidosis
Vaishali Sanchorawala • 15 Sep 2020

Diagnosis

View all
2:20
New prognostic markers in AL amyloidosis
Efstathios Kastritis • 15 Sep 2020
4:10
MRD using multi-parametric flow cytometry in AL amyloidosis
Andrew Staron • 10 Sep 2020
1:19
AL Amyloidosis: MRD negativity
Nelson Leung • 3 Sep 2020

AA Amyloidosis

View all
0:52
Tocilizumab for AA amyloidosis
Luis Quintana • 4 Sep 2020
1:04
AA amyloidosis management
Luis Quintana • 10 Sep 2020

ATTR Amyloidosis

View all
10:09
ISA 2020: continuing the amyloidosis conversation
Joan Bladé • 2 Sep 2020
15:21
Genetic signatures & hereditary ATTR amyloidosis
Joel Buxbaum • 3 Sep 2020

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals